Striatal glutamatergic mechanisms and extrapyramidal movement disorders
Author:
Publisher
Springer Science and Business Media LLC
Subject
Toxicology,General Neuroscience
Link
http://link.springer.com/content/pdf/10.1007/BF03033378.pdf
Reference105 articles.
1. Ahlskog JE and MD Muenter (2001) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.Mov. Disord. 16, 448–458.
2. Ahn S, DD Ginty and DJ Linden (1999) A late phase of cerebellar long-term depression requires activation of CaMKIV and CREB.Neuron 23, 559–568.
3. Andersson M, A Hilbertson and MA Cenci (1999) Striatal fosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease.Neurobiol. Dis. 6, 461–474.
4. Anglade P, A Mouatt-Prigent, Y Agid and E Hirsch (1996) Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease.Neurodegeneration 5, 121–128.
5. Bartsch D, A Casadio, KA Karl, P Serodio and ER Kandel (1998) CREB1 encodes a nuclear activator, a repressor, and a cytoplasmic modulator that form a regulatory unit critical for long-term facilitation.Cell 95, 211–223.
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antagonism of metabotropic glutamate receptor type 5 prevents levodopa‐induced dyskinesia development in a male rat model of Parkinson's disease: Electrophysiological evidence;Journal of Neuroscience Research;2024-03
2. The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson’s Disease;Advances in Therapy;2023-12-09
3. The effects of safinamide according to gender in Chinese parkinsonian patients;Scientific Reports;2023-11-23
4. Safety review of current pharmacotherapies for levodopa-treated patients with Parkinson’s disease;Expert Opinion on Drug Safety;2023-07-03
5. The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson’s Disease with Motor Fluctuations;CNS Drugs;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3